Skip to content

Development of a mindfulness-based treatment for smoking cessation and the modification of alcohol use: A protocol for a randomized controlled trial and pilot study findings.

Mikaela Hemenway, Katie Witkiewitz, Marina Unrod, Karen O Brandon, Thomas H Brandon, David W. Wetter, Steven K. Sutton, Christine Vinci

Contemporary Clinical Trials November 14, 2020 DOI: 10.1016/j.cct.2020.106218 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study and randomized controlled trial protocol Peer reviewed
Sample size 21
Population People who smoke cigarettes and use alcohol
Intervention Mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
Duration Eight weekly treatment sessions
Topics Meditation
Keywords Humans Pilot projects Smoking cessation Tobacco smoking Randomized controlled trial Pilot study Alcohol use
Key findings The authors report that the eight-session MBRP-SA pilot was acceptable enough to participants that they intended to use the skills in daily life and for their smoking and alcohol goals, and they describe plans for a randomized trial testing live online MBRP-SA as a primary treatment for smoking cessation and alcohol modification.

Abstract

The combined use of cigarettes and alcohol is associated with an increased risk of morbidity and mortality. Yet, efficacious interventions that address both behaviors concurrently are lacking. Smoking cessation and alcohol modification not only garner health benefits, but there is also value in addressing alcohol use in the context of smoking cessation to reduce the risk for smoking relapse. In this paper we describe the development of mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA) and pilot study findings (Phase 1). Next, details regarding the methods and design of an ongoing, randomized controlled trial, Project RISE (Phase 2), are described. MBRP-SA is a group-based intervention that consists of eight weekly treatment sessions. Results from the Phase 1 pilot study (N = 21 enrolled) indicated that participants planned to use the skills learned in their everyday activities and to address their smoking and alcohol goals. Based on the progression of Phase 1 cohorts, modifications were made to the inclusion/exclusion criteria and recruitment methods that will be implemented in Phase 2. Phase 2 will assess the feasibility and acceptability of MBRP-SA, delivered via live online groups, as a primary treatment option for smoking cessation and alcohol use modification.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics